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ABSTRACT
Nutrient iron sequestration is the most significant form of nutritional immunity and causes bacterial
pathogens to evolve strategies of host iron scavenging. Cigarette smoking contains iron particulates
altering lung and systemic iron homeostasis, which may enhance colonization in the lungs of patients
suffering chronic obstructive pulmonary disease (COPD) by opportunistic pathogens such as nontype-
able. NTHi is a heme auxotroph, and the NTHi genome contains multiple heme acquisition systems
whose role in pulmonary infection requires a global understanding. In this study, we determined the
relative contribution to NTHi airway infection of the four heme-acquisition systems HxuCBA, PE,
SapABCDFZ, and HbpA-DppBCDF that are located at the bacterial outer membrane or the periplasm.
Our computational studies provided plausible 3D models for HbpA, SapA, PE, and HxuA interactions
with heme. Generation and characterization of singlemutants in the hxuCBA, hpe, sapA, and hbpA genes
provided evidence for participation in heme binding-storage and inter-bacterial donation. The hxuA,
sapA, hbpA, and hpe genes showed differential expression and responded to heme. Moreover, HxuCBA,
PE, SapABCDFZ, and HbpA-DppBCDF presented moonlighting properties related to resistance to
antimicrobial peptides or glutathione import, together likely contributing to the NTHi-host airway
interplay, as observed upon cultured airway epithelia and in vivo lung infection. The observed multi-
functionality was shown to be system-specific, thus limiting redundancy. Together, we provide evidence
for heme uptake systems as bacterial factors that act in a coordinated and multi-functional manner to
subvert nutritional- and other sources of host innate immunity during NTHi airway infection.
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The need of invading bacteria to acquire nutrient metals
from their environments has caused vertebrate hosts to
evolve to restrict their bioavailability. Nutrient iron
sequestration is one mode of innate defence termed
“iron nutritional immunity”, whereby iron levels are
tightly controlled by host regulatory systems controlling
its absorption, systemic transport, distribution, cellular
uptake, and storage [1,2]. In response to this, pathogens
evolve mechanisms of host iron piracy to scavenge this
metal during infection [3].
Iron exists in the reduced ferrous (Fe2+) or oxidized
ferric (Fe3+) forms. The Fe2+/Fe3+ redox potential makes
it extremely versatile when incorporated into proteins as
a catalytic center or electron carrier, and it is essential in
numerous biological processes. Although abundant in
nature, iron does not normally occur in its biologically
active ferrous form. Under aerobic conditions, Fe2+ is
unstable and generates Fe3+ and reactive oxygen species
(ROS) via the Fenton reaction, the latter of which can
damage lipids, DNA, and proteins [4]. Conversely, ferric
iron is poorly water-soluble and requires specialized pro-
teins to facilitate its mobilization and maintain intracel-
lular reservoir (lactoferrin and transferrin for transport,
ferritin for storage). However, the most abundant form of
iron in vertebrates is bound within a porphyrin ring as
ferriprotoporphyrin IX (heme) [5], most of which is
bound to intracellular proteins (hemoglobin, myoglobin,
cytochromes). Hemoglobin from lysed erythrocytes is
bound by haptoglobin, whereas free heme is bound to
hemopexin and, to a lesser extent, to albumin, under
which circumstances it may become available to
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extracellular pathogens [6]. Many pathogens thus exploit
host heme as a nutrient iron source [5,7,8].
In the lungs, iron is stored in ferritin, macrophages
sequester heme from senescent erythrocytes, take and
store iron from transferrin, and clear inhaled iron-
containing particulate matter. Likewise, neutrophils release
iron regulatory molecules helping sequester free iron [9–
11]. Human lung iron levels range between 0.4–0.9 mg/g,
and ~10 μg iron are exposed to lungs daily at a normal rate
of breathing from the atmosphere [12]. Exposure to higher
iron levels through inhalation of iron-containing particu-
late matter provides catalytically active iron resulting in
tissue damage. Moreover, alveolar hemorrhaging observed
in several lung disease conditions leads to increased iron
levels. As a consequence, strong evidence for dysregulated
iron homeostasis exists in major respiratory diseases
including chronic obstructive pulmonary disease (COPD)
[1,2,13–15]. COPD is a complex progressive condition
characterized by chronic airway inflammation, associated
with airway remodeling, alveolar destruction and persistent
airflow obstruction [16]. Cigarette smoking, the single
greatest risk factor for developing COPD [17], contains
iron particulates inducing intracellular iron accumulation
[13,14]. Elevated levels of iron, ferritin, and oxidative stress
are found in the lungs of smokers, where alveolar macro-
phages increase iron loading [13,14,18–20]. Similarly, the
COPD airways present altered levels of iron-binding pro-
teins, increased iron loading by alveolar macrophages, and
high rates of polymorphisms in genes associated with iron
regulation [21–28]. Given that iron overload increases the
virulence of numerous pathogens [29,30], dysregulation of
iron homeostasis in the COPD lungs may also facilitate
persistence by opportunistic pathogens in the lower air-
ways [2,6,11].
Nontypeable Haemophilus influenzae (NTHi) is typi-
cally a commensal of the human upper airways, but also
a common opportunistic pathogen in the lower airways of
patients with COPD [31–35]. NTHi persistence within the
COPD lungs contributes to airway inflammation that
results in worsening of symptoms and promotes disease
progression [33,36–38]. NTHi is incapable of synthesizing
heme, but possesses a ferrochelatase that reversibly inserts
iron into protoporphyrin IX (PPIX) to form heme [39,40].
Thus, it requires either iron in the presence of PPIX or
exogenous heme to grow aerobically [41]. NTHi presents
a variety of heme uptake-binding systems including TonB-
dependent outer membrane systems that bind heme or
hemoproteins (Hup [42], HemR [43], Hgps [44–50],
HxuCBA [51–56]), and TonB-independent periplasmic
proteins that bind heme and are linked to inner membrane
ABC transporters (SapABCDFZ, HbpA-DppBCDF [57–
62]). NTHi also stores and shares heme by using the
outer membrane protein E (PE) [63] (Figure 1).
Information on the contribution of heme uptake to NTHi
respiratory infection is scattered [47,50,55,60,64], and
a global understanding is lacking.
Existing evidence prompted us to hypothesize that
pathological disruption of lung iron homeostasis and bac-
terial heme auxotrophy may have evolved NTHi toward
the coordinated action of its repertoire of heme scavenging
mechanisms, to evade nutritional immunity and facilitate
the host-pathogen interplay. In this study, HxuCBA, PE,
SapABCDFZ, and HbpA-DppBCDF were selected as
representative H. influenzae heme binding systems at the
outer membrane and within the periplasm (Figure 1).
Systematic bacterial gene inactivation and phenotypic
assessment revealed their relative contribution to NTHi




Docking of heme B to HbpA, SapA, PE, and HxuA
was performed using the HADDOCK2.2 (High
Figure 1. Schematic representation of NTHi heme uptake systems considered in this study. HxuCBA is a TonB-dependent system
involved in heme-hemopexin binding. HxuC is a receptor and HxuAB is a two-partner secretion system. HxuA is exposed at the cell surface,
and leads to heme release and its capture by HxuC. SapABCDFZ, HbpA-DppBCDF and PE are TonB-independent systems. SapA and HbpA are
periplasmic proteins that bind heme and are linked to the inner membrane ABC transporters SapBCDFZ and DppBCDF, respectively. PE is an
outer membrane protein that binds heme as a dimer. The HitABC free iron uptake system is also shown. HitA is a periplasmic protein that
binds free iron linked to the HitBC transporter located at the inner membrane. Heme-iron sources are color-coded.
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Ambiguity-Driven protein-protein DOCKing) server
[65,66]. For HbpA and SapA, the I-TASSER server
[67,68] was used to generate homology models based
on the crystal structure of HbpA from Haemophilus
parasuis in its ligand-bound form (PDB code 3M8U)
[62]. For both proteins, the best scoring I-TASSER
model was used for the docking experiment. To drive
the docking, residues with 60% ligand binding prob-
ability as estimated by the COACH function within
the I-TASSER suite [69,70] were included as part of
an initial estimation of the location of the binding
site (residues 61–64, 155, 280, 396, 398, 445–447, and
537 for HbpA; residues 54–55, 458–460, and 462 for
SapA). In addition to full-length SapA, heme docking
was also performed after removing residues 140–158.
For PE, heme was docked to the crystal structure of
the PE-dimer (3ZH5). Residues from both monomers
within the predicted heme binding pocket (59, 65, 67,
94, 96, 98, 101, 103, and 107) were used to drive the
docking. For HxuA, heme was docked to the HxuA
crystal structure (PDB code 4RM6), and residues in
a manually identified putative binding pocket (450,
452, 464, 516, 526, 556, 560, and 572) were used to
drive the docking. Docking solutions were evaluated
based on the HADDOCK score and Z-score (the
number of standard deviations the HADDOCK
score of a given solution is separated from the
mean of all clusters). For HbpA, truncated SapA,
and PE, a single statistically significant solution clus-
ter was obtained (p < 0.05) whereas for HxuA, two
equally good solutions were obtained. For full-length
SapA, a second solution (cluster 4) with a non-
significantly different HADDOCK score from the
top solution was obtained. However, this was
discarded due to the significantly higher Z-score
(−0.2 compared to −1.7 for the top solution).
Detailed docking statistics are given in Table S4.
The top solution in each cluster was further analyzed
in PyMOL (PyMOL Molecular Graphics System, ver-
sion 2.0, Schrödinger, LLC), and LigPlot+ [71], which
were also used to generate figures.
Bacterial strains, plasmids, and growth media
Strains and plasmids used in this study are described in
Table 1 and Table S1. NTHi strains were grown for
16 h, at 37°C, 5% CO2, on chocolate agar (Biomérieux),
Mueller Hinton-Fastidious agar (MH-F) (Biomérieux),
Haemophilus Test Medium agar (HTM, Oxoid), or
Brain-Heart Infusion agar (BHI, Oxoid). BHI was sup-
plemented with 10 μg/ml nicotinamide adenine dinu-
cleotide (NAD, factor V) (Sigma-Aldrich) (referred to
as BHI-NAD or heme-deficient medium).
Alternatively, HTM and BHI were supplemented with
both NAD and 10 μg/ml heme (factor X) (Sigma-
Aldrich) (referred to as sHTM and sBHI). Liquid cul-
tures were grown in heme-deficient medium, sBHI or,
alternatively, in a chemically defined minimal medium
(CDMM) supplemented with 50 μM cystine (Sigma-
Aldrich) or 50 μM glutathione disulfide (GSSG)
(Sigma-Aldrich) (Table S2 [62,72,73]). GSSG (20 mM)
was prepared in sterile water; 20 mM cystine was pre-
pared in 1M HCl, filtered and maintained at 4°C until
use. Erythromycin (Erm) at 11 μg/ml or spectinomycin
(Spec) at 50 μg/ml was used when required. Escherichia
coli was grown on Luria Bertani (LB) agar at 37°C,
supplemented with ampicillin at 100 μg/ml, Erm at
150 μg/ml, or Spec at 50 μg/ml, when indicated.
Table 1. Bacterial strains used in this study.
Strain Description Source
H. influenzae
NTHi375 Wild-type, otitis media clinical isolate [117]
NTHi375ΔhxuCBA-P682 hxuCBA::spec, SpecR This study
NTHi375ΔsapA-1665 sapA::ermC::ermC, ErmR This study
NTHi375ΔhbpA-P896 hbpA::spec, SpecR This study
NTHi375Δhpe-P897 hpe::spec, SpecR This study
RdKW20 Laboratory strain, capsule-deficient serotype d [97]
RdKW20ΔhxuCBA-P683 hxuCBA::spec, SpecR This study
RdKW20ΔsapA-P578 sapA::ermC::ermC, ErmR This study
RdKW20ΔhbpA-P885 hbpA::spec, SpecR This study
RdKW20ΔhitBC-P804 hitBC::ermC, ErmR This study
NTHi3655luxABCDE-P845 Luminiscent strain derived from isolate NTHi3655. It contains a copy of the luxABCDE operon
inserted in the genome.
[63]
E. coli
TOP10 Used for cloning assays Thermofisher Scientific
SW102 Derived from DY380, it contains a defective λ prophage with the recombination proteins exo, bet,
and gam being controlled by the temperature-sensitive repressor cI857
[75]
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Generation of H. influenzae mutant strains
Plasmids, primers, and construct design are shown in
Tables S1, S3, and Fig. S1A. Briefly, a DNA fragment
containing each gene/operon and its respective flanking
regions was PCR amplified with Phusion polymerase
(ThermoScientific) using NTHi375 genomic DNA as
template and primers gene+flanking region-F1 and
gene+flanking region-R1, and cloned into pJET1.2/
blunt (ThermoScientific) or pGEMT-easy (Promega),
generating plasmids pJET1.2-hxuCBA, pGEMT-sapAB,
pJET1.2-hbpA, and pJET1.2-hpe. To generate
pJET1.2-hitABC, two DNA fragments of the hitABC
operon were independently amplified using primers
hitABC-F1/hitABC-R2 and hitABC-F2/hitABC-R1,
respectively, KpnI digested and ligated, rendering
a product with a 853 bp deletion of the hitB gene 3´
end and a 200 bp deletion of the hitC gene 5´ end,
which was further amplified with primers hitABC-F1
and hitABC-R1 and cloned into pJET1.2 to generate
pJET1.2-hitABC. An Erm-based disruption strategy was
used to generate ΔsapA and ΔhitBC strains. pGEMT-
sapAB was disrupted by inverse PCR with Phusion
polymerase, using primers sapAB-F2 and sapAB-R2.
A sapA gene internal fragment of 168 bp was replaced
by a blunt-ended ErmC resistance cassette excised by
SmaI digestion from pBSLerm [74], generating
pGEMT-sapA::ermC, which was used as a template to
amplify the sapA::ermC disruption cassette with pri-
mers sapAB-F1 and sapAB-R1. pJET1.2-hitABC was
KpnI digested and used as cloning vector for
a KpnI blunt-ended ErmC resistance gene excised by
KpnI digestion from pBSLerm, generating
pJET1.2-hitBC::ermC, which was used as a template to
amplify the hitBC::ermC disruption cassette with pri-
mers hitABC-F1 and hitABC-R1. Alternatively, a Spec-
based disruption strategy was used to generate
ΔhxuCBA, ΔhbpA, and Δhpe strains. To do so, a Spec
resistance gene was independently PCR amplified from
pRSM2832 using gene-specific mutagenic primer pairs
hxuCBA-F2/hxuCBA-R2, hbpA-F2/hbpA-R2, and hpe-
F2/hpe-R2 [75]. E. coli SW102 cells were prepared for
recombineering, separately co-electroporated with
pJET1.2-hxuCBA, pJET1.2-hbpA or pJET1.2-hpe
(Ampr) (50 ng), and with each gene-specific mutagenic
cassette (Specr) (200 ng) [76]. Mutagenized clones con-
taining pJET1.2-hxuCBA::spec, pJET1.2-hbpA::spec and
pJET1.2-hpe::spec were selected on LB agar with
Amp100 and Spec50. These plasmids were used as tem-
plates to amplify the hxuCBA::spec, hbpA::spec and
hpe::spec disruption cassettes with primer pairs
hxuCBA-F1/hxuCBA-R1, hbpA-F1/hbpA-R1, and hpe-
F1/hpe-R1, respectively. Disruption cassettes were
independently used to transform NTHi375 or Hi
RdKW20 by using the MIV method [77].
Transformants were selected on sBHI agar with Erm
at 11 μg/ml to obtain ΔsapA and ΔhitBC strains, and on
sBHI agar with Spec at 50 μg/ml to obtain ΔhxuCBA,
ΔhbpA, and Δhpe strains. All mutants were confirmed
by PCR and sequencing. The sapABCDFZ and hbpA-HI
0854/NTHI1022 are gene clusters containing 6 and 2
genes, respectively. Expression of the sapBCDFZ and
HI0854/NTHI1022 genes in NTHi375ΔsapA and
NTHi375ΔhbpA strains was tested by RT-PCR (see
below), being comparable to that found in the wild
type (WT) strain (Fig. S1B).
Bacterial growth
Strains grown on chocolate agar were used to generate
bacterial suspensions normalized in PBS to OD600 = 1.
Suspensions were spread on 20 ml BHI agar in the
presence of sterile X + V factor disks (Oxoid), and
grown during 20 h at 37°C. Growth diameter was
measured on at least three independent occasions
(n ≥ 3). Alternatively, normalized bacterial suspensions
were diluted to OD600 = 0.05 in 2 ml sBHI, and 200 µl
aliquots were transferred to individual wells in 96-well
microtiter plates (Falcon). Plates were incubated with
agitation at 37°C for 6 h in a Multiskan device
(ThermoScientific), and OD636 was monitored every
15 min. Each growth curve was corrected to its blank
values (sBHI). Independently, strains were grown on
chocolate agar; biomass was inoculated in 7 ml sBHI
and incubated for 8 h at 37°C with shaking (200 r.p.m.).
Cultures were centrifuged (10 min, 4000 r.p.m.) and
suspensions were normalized to OD600 = 1 in PBS.
Then, 180 μl of CDMM supplemented with either
50 μM cystine or 50 μM GSSG were transferred to
individual wells in 96-well microtiter plates (Sarstedt).
Thereafter, 20 μl of the previously prepared bacterial
suspensions were added to each well. Plates were incu-
bated in a SpectraMAX 340 microplate reader at 37°C,
and OD600 was recorded every 30 min for 8 h. In all
cases, bacterial growth was monitored in triplicate at
least three times (n ≥ 9).
Heme binding to the bacterial surface
As previously stated [63], strains were grown on cho-
colate agar, inoculated in 5 ml heme-deficient medium
and grown for 8 h, at 37°C with shaking (200 r.p.m.).
Next, 100 μl culture aliquots were inoculated into 20 ml
sBHI and grown for 16 h under the same conditions.
Normalized bacterial suspensions were collected by
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centrifugation (10 min, 4000 r.p.m.), washed three
times with PBS, and resuspended in 5 ml PBS. For
semi-quantitative determination of bacterial heme,
5 ml PBS suspensions were 2-fold serially diluted in
PBS, 100 µl aliquots spotted on PVDF membranes, and
heme was detected by an enhanced chemiluminescence
(ECL) Western Blot detection kit (Pierce).
Co-culture of NTHi3655luxABCDE with heme donors
NTHi3655luxABCDE (recipient) was co-cultured with
H. influenzae heme donors [63]. Donor strains were
grown on chocolate agar, inoculated in 5 ml heme-
deficient medium, and grown for 8 h with shaking
(200 r.p.m.). Thereafter, 100 µl aliquots of these cul-
tures were added to 20 ml sBHI and grown for 16 h
under the same conditions. To generate heme starva-
tion, NTHi3655luxABCDE was grown on chocolate
agar, inoculated in 20 ml heme-deficient medium, and
grown overnight with shaking (200 r.p.m.). All cultures
were then recovered by centrifugation (10 min, 4000 r.
p.m.), washed twice in BHI, and resuspended in 10 ml
BHI. For co-cultures, appropriate volumes of each sus-
pension (donor and recipient) containing identical
number of colony forming units (CFU) were mixed in
5 ml heme-deficient medium generating a starting co-
culture with OD600 = 0.1, to be incubated for 6 h. For
recipient controls, similar NTHi3655luxABCDE cul-
tures were prepared and grown in sBHI or heme-
deficient medium (positive and negative controls,
respectively). Luminescence was monitored every hour
for 6 h in a 1,450 MicroBeta TriLux counter
(PerkinElmer), using 100 µl bacterial culture aliquots
and 96-well black plates (Uniplate®, Whatman).
Experiments were performed in triplicates at ≥ 3 inde-
pendent occassions (n ≥ 9).
Bacterial susceptibility to antimicrobials
Antibiotic minimal inhibitory concentrations (MICs)
were determined by microdilution using commercial
panels (STRHAE2; Sensititre), and interpreted by fol-
lowing the criteria of the Clinical Laboratory Standards
Institute (CLSI) [78]. For polymyxin E (PxE), Etests
(Biomérieux) on MH-F agar were performed: bacteria
were grown on chocolate agar for 8 h, inoculated in
7 ml of heme-deficient medium or sBHI, and grown for
12 h at 37°C, 200 r.p.m. Cultures were centrifuged
(10 min, 4000 r.p.m.), suspensions normalized to ~0.5
McFarland (equivalent to OD600 = 0.063) in saline
solution, and used as inoculum on MH-F agar
(n = 2). To monitor susceptibility to H2O2, bacteria
grown on chocolate agar for 8 h were inoculated in
7 ml of sBHI, and grown for 12 h at 37°C, 200 r.p.m.
Cultures were centrifuged (10 min, 4000 r.p.m.), sus-
pensions were normalized to OD600 = 1 (~7×10
8 CFU/
ml) in PBS and plated on sHTM agar on large Petri
dishes (20 cm diameter; 80 ml sHTM agar/plate; 1.8 ml
suspension/plate). H2O2 at 9.8 M (Sigma-Aldrich) was
used as stock solution to be diluted in sterile distilled
water. Sterile paper disks soaked on 10 μl H2O2 con-
taining 25 or 50 μmol were located on the sHTM agar
and incubated for 20 h at 37°C. Results are shown as
diameter of bacterial growth inhibition (mm) around
H2O2 disks (means ± SD). Assays were performed at ≥
3 independent occassions (n ≥ 3).
RNA extraction and real-time quantitative PCR (RT-
qPCR)
Two to 5 colonies of strains grown on chocolate agar
were inoculated in 20 ml sBHI, grown for 11 h, diluted
into 40 ml fresh sBHI to OD600 = 0.05, and grown to
OD600 = 0.5–0.6 (named as conventional sBHI cul-
tures). Alternatively, bacterial biomass was collected
from chocolate agar, inoculated in 5 ml heme-
deficient medium and grown for 8 h. Next, 100 μl
aliquots were inoculated into 20 ml sBHI and grown
overnight (37°C, 5% CO2, 200 r.p.m.). Overnight cul-
tures were collected by centrifugation (10 min, 4000 r.
p.m.), washed 3 times in PBS, resuspended in 5 ml PBS,
diluted to OD600 = 0.05 in 40 ml fresh BHI-NAD or
sBHI, and grown to OD600 = 0.4–0.5 [63]. Bacterial
total RNA was isolated using TRIzol reagent
(Invitrogen), and total RNA quality evaluated using
RNA 6,000 Nano LabChips (Agilent 2,100
Bioanalyzer, Santa Clara, CA). All samples had intact
23S and 16S ribosomal RNA bands. Reverse transcrip-
tion (RT) was performed using 1 µg of RNA by
PrimerScript RT Reagent kit (Takara). PCR amplifica-
tion was performed by using SYBR Premix Ex Taq II
(Tli RNaseH Plus) (Takara). Fluorescence was analyzed
with AriaMx Real-Time PCR System (Agilent
Technologies). The comparative threshold cycle (Ct)
method was used to obtain relative quantities of
mRNAs that were normalized using 16S ribosomal
RNA (16SrRNA) as an endogenous control. Primers
were designed with Primer3 software (Table S3). All
cultures were grown at least three times, and samples
were processed with technical triplicates (n ≥ 3).
Cell culture and bacterial infection
A549 type II human pneumocytes (ATCC CCL-185)
were maintained and seeded as described [79–86]. For
infection, PBS-normalized bacterial suspensions
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(OD600 = 1) were prepared by using NTHi strains
grown on chocolate agar. Alternatively, bacteria
grown on chocolate agar were inoculated in 7 ml heme-
deficient medium or sBHI, and grown for 12 h at 37°C,
200 r.p.m. Cultures were centrifuged (10 min, 4000 r.p.
m.), suspensions normalized to OD600 = 1 in PBS, and
then used as infecting inoculum. A multiplicity of
infection (MOI) of ~100:1 was used. To monitor adhe-
sion, cells were infected for 30 min. This assay does not
completely exclude a possible internalization of some
bacteria, and experimental conditions were previously
set to mainly monitor adhesion [84]. For invasion test-
ing, cells were incubated with bacteria for 2 h, washed 3
times with PBS, incubated for 1 h with RPMI 1640
medium containing 10% FCS, 10 mM Hepes, and
200 µg/ml gentamicin. After infection, cells were lysed
with PBS-saponin 0.025%, 10-fold diluted and plated
on sBHI agar. All infections were performed in tripli-
cates at ≥ 3 independent occassions (n ≥ 9). Results are
expressed as CFU/well.
Secretion of IL-8
Bacteria grown on chocolate agar were collected with
PBS, suspensions normalized to OD600 = 1 and used for
2 h infection with a MOI of ~100:1. Cells were washed
three times with PBS, and incubated for 6 h in RPMI
1640 medium containing 10% FCS, 10 mM Hepes, and
100 µg/ml gentamicin. Supernatants were collected from
the wells, cell debris was removed by centrifugation and
samples were frozen at −80°C. IL-8 levels in superna-
tants were measured by ELISA (Abnova KA0115) with
sensitivity <2 pg/ml. Infections were performed in dupli-
cate and at least twice (n = 4). Results on IL-8 are
expressed in pg/ml.
NTHi mouse lung infection
A mouse model of NTHi lung infection was used as
described previously [86]. CD1 female mice were pur-
chased from Charles River Laboratories (France), housed
under pathogen-free conditions at the Institute of
Agrobiotechnology facilities (registration number 365
ES/31-2016-000002-CR-SU-US), and used at 22–25 g
(6–7 weeks). Animal handling and procedures were in
accordance with the current European (Directive 2010/
63/EU) and National (Real Decreto 53/2013) legislations,
following the FELASA and ARRIVE guidelines, with the
approval of Universidad Pública de Navarra (UPNa)
Animal Experimentation Committee, and in accordance
with the Helsinki declaration. Bacteria grown on choco-
late agar were recovered in PBS generating normalized
suspensions (~5 × 109 CFU/ml). Next, 20 µl suspensions
(~1 × 108 CFU/mice) were placed at the entrance of the
nostrils until complete inhalation, in mice previously
anesthetized with ketamine-xylazine (3:1). At 24 or 48 h
post-infection (hpi), mice were euthanized using cervical
dislocation. Bronchoalveolar lavage fluid (BALF) samples
were obtained by perfusion and collection of 0.7 ml of
PBS, with help of a sterile 20G (1.1 mm diameter)
VialonTM intravenous catheter (Becton-Dickinson)
inserted into the trachea. Recovered BALFwas serially 10-
fold diluted in PBS, and plated in triplicate on sBHI agar
to determine the number of viable bacteria. By following
standardized published procedures [87], we considered
that we could have a minimum of 3.3 CFU in 1 ml of
sample without detecting bacteria (limit of detection
<3–4 CFU/ml BALF), rendering log10 = 0.52. The left
lung was individually weighed in sterile bags
(Stomacher80, Seward Medical) and homogenized 1:10
(wt/vol) in PBS. Each homogenate was serially 10-fold
diluted in PBS and plated in triplicate on sBHI agar to
determine the number of CFU per lung. Infections were
performed in groups of at least five mice per strain and
time point (n ≥ 5).
Statistical analysis
In all cases, p < 0.05 value was considered statistically
significant. Analyses were performed using Prism soft-
ware, version 7 for Mac (GraphPad Software) statistical
package, and are detailed in each figure legend.
Results
Structural basis of heme binding to the HbpA,
SapA, PE, and HxuA proteins
First, we investigated the ability of HxuA, HbpA, PE,
and SapA to bind heme in silico using the HADDOCK
(High Ambiguity-Driven Protein DOCKing) server
[65,66]. HxuA is part of the heme-hemopexin heme
transport system which consists of the HxuC and the
two-partner secretion system HxuBA. HxuA is exposed
at the cell surface, and its interaction with hemopexin
leads to heme release and its capture by HxuC [51–56].
PE is an outer membrane lipoprotein, the dimer of
which has been proposed to bind heme [63]; and
SapA and HbpA are Cluster C substrate-binding pro-
teins (SBP) that locate at the periplasm and act in
concert with the SapBCDFZ and DppBCDF inner
membrane ABC transporters, respectively [57,59–62].
Docking results for all four proteins are summarized in
Table S4.
Since there are no crystal structures of HbpA and SapA,
homology models were constructed based on the crystal
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structure of HbpA from H. parasuis (HpHbpA) in its
glutathione-bound form (PDB code 3M8U) [62] using
I-TASSER [67,68]. The sequence identity for the structu-
rally aligned region was 74% and 30% for HbpA and SapA,
respectively. Despite the lower sequence identity for SapA,
a sequence alignment with HbpA,HpHbpA and the struc-
turally homologous dipeptide-binding protein DppA from
E. coli (EcDppA) [88] confirmed high sequence similarity
(Fig. S2), supporting HpHbpA as a good structural tem-
plate for SapA as well as HbpA. Ligand binding site resi-
dues predicted by COACH [69,70], a ligand-binding
prediction server integrated into I-TASSER suite, was
used to drive the docking.
For HbpA, the highest scoring docking solution sug-
gests heme binding at a cleft between the N-terminal and
C-terminal domains (Figure 2(a–e)), similar to what is seen
for binding of glutathione and dipeptide to HpHbpA and
EcDppA respectively (Fig. S3A-B). In SapA, heme docks in
a similar location but at a different angle due to the pre-
sence of a longer loop (residues 140–158, in orange in
Figure 2(a,b)). This loop extension is not conserved in
HbpA, HpHbpA and EcDppA, and thus seems to be
a unique feature of SapA (Fig. S2). Since the position of
this loopmust be regarded as speculative due to its absence
in the homology modeling template, we removed it from
the SapA homology model and repeated the docking
experiment. In the absence of the extended loop, the pre-
dicted heme binding mode is closer as to what is seen for
HbpA, although the site is closer to the protein surface.
Analysis of the heme binding sites using LigPlot+ [71]
shows predicted hydrogen bonds between heme propio-
nates and positively charged side chains or main chain
nitrogens in all three cases, as well as the presence of
hydrophobic residues lining the pockets and providing
van der Waals interaction with the rest of the heme group
(Figure 2(c-e) and Fig. S3C-D). Despite the differences in
heme binding mode, several residues are common for all
three binding sites (colored yellow in Figure 2(c–e)).
For HbpA, the suggested site is supported by what has
been previously predicted [89] and corresponds well to
a very recent study where heme was docked to HpHbpA,
OppA from H. influenzae (HiOppA) and NikA from
Figure 2. Structural prediction of heme binding to HbpA and SapA. HADDOCK was used to dock heme B to homology models of
HbpA (green), full-length SapA (grey) and truncated SapA (purple) in which a non-conserved loop consisting of residues 140–158 has
been removed. The truncated residues are colored orange in full-length SapA. (a) Overlay of the best scoring docking solutions for
HbpA, SapA and truncated SapA. (b) Zoom-in on predicted heme binding sites showing how HbpA binds heme deeper into the
ligand-binding pocket. In full-length SapA, the non-conserved loop (orange) prevents heme binding into the same pocket whereas
in truncated SapA, the pocket is more accessible. (c-e) LigPlot+ analysis of the predicted heme binding site in HbpA (c), full-length
SapA (d) and truncated SapA (e) with residues lining the binding sites in stick representation. Predicted hydrogen bonds are showed
as dashed lines. Residues that are common for all three binding sites are colored yellow.
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E. coli (EcNikA) [90]. In the latter study, heme was sug-
gested to bind in a site that was distinct but close to the
site for other ligands (glutathione for HpHbpA, peptide
for HiOppA, and butane-1,2,4-tricarboxylate-chelated
nickel for EcNikA) and the ability of bind heme and
other ligands simultaneously was demonstrated using
surface plasmon resonance. Our docking results reveal
a similar scenario, with heme binding close to- but not
overlapping with the binding site for glutathione in
HpHbpA (Fig. S3).
From the crystal structure of PE, it was suggested
that heme could bind in a well-defined pocket
formed at the PE dimer interface. Manual docking
of heme into this pocket showed that it should be
able to accommodate heme but no additional evalua-
tion was performed [63,91]. Here we further explored
heme binding to PE by docking heme into the pre-
dicted heme-binding pocket. Our results show that
heme fits very well with predicted hydrogen bonds
formed between heme propionates and polar residues
within one of the PE monomers (Asn98, Asn101, and
Thr105), as well as van der Waals interactions with
hydrophobic residues on both sides of the pocket
(Ile65 and Ile96) (Fig. S4A-C).
While HxuC reconstitution in E. coli previously
showed its ability to act independently as a functional
free heme receptor [53], direct heme binding to HxuA
has not been demonstrated. Nevertheless, upon exam-
ination of the HxuA crystal structure (PDB code 4RM6)
[92], we identified a pocket at the HxuA surface, close to
the hemopexin binding site, that showed similarities
with the predicted heme binding site in HbpA as indi-
cated above, most notably the presence of several posi-
tively charged residues that may interact with heme
propionates. The ability of this pocket to accommodate
a heme molecule was investigated using HADDOCK,
resulting in two solutions with similar docking scores
(Table S4). As shown in Fig. S4D-E, heme fits well into
this pocket, with the two solutions differing by the heme
propionates pointing into or out of the pocket. In both
solutions, several positively charged residues (Arg and/
or Lys) are well positioned to interact with heme pro-
pionates via hydrogen bonds.
In summary, our computational studies provide plau-
sible 3D models for how HbpA, SapA, PE, and HxuA
interacts with heme.
Expression of NTHi heme binding protein encoding
genes and their response to heme availability
H. influenzae genes encoding heme-binding proteins are
transcribed during acute infection [93]. Multiple heme
acquisition systems may counteract NTHi heme
auxotrophy and human iron nutritional immunity, but
could also lead to redundancy. Based on these assumptions,
we asked if the systems under analysis could be inter-
related to preserve bacterial fitness or prevent heme over-
loading toxicity, and if such relationship may occur at the
gene expression level.
The NTHi375 strain was employed to independently




NF38_04540) (Table 1). Initial characterization of the
generated mutants rendered the following features: (i)
growth in sBHI, with slightly longer lag phase for the
hxuCBA, hbpA, and hpe mutants than for the WT
strain (Fig. S5A). (ii) Aerobic growth on BHI agar
around X + V factor disks comparable to that of the
WT strain, except for ΔhxuCBA, whose growth showed
a trend to be lower (NTHi375 WT, 138 ± 17 mm;
NTHi375ΔhxuCBA, 122 ± 18 mm) (Fig. S5B). (iii)
Anaerobic growth on BHI agar around V factor disks,
and antibiotic susceptibility patterns (Table S5) similar
to the WT strain. (iv) Inactivation of heme acquisition
systems could modify bacterial iron levels and subse-
quently, iron reactivity with H2O2 via the Fenton reac-
tion. To prove this phenomenon, inactivation of the
sapA and hbpA genes increased growth inhibition
around paper disks soaked with H2O2 25 and 50 μmol
compared to the WT strain (Fig. S5C).
NTHi375 WT and mutant strains were used to
determine the expression of the hxuA, sapA, hbpA,
and hpe genes. First, conventional sBHI cultures were
employed. The hbpA gene was highly expressed in all
cases, with higher expression than that of the hxuA,
sapA, and hpe genes. Inactivation of the hxuA, sapA,
and hpe genes did not alter hbpA gene expression.
However, expression of the hxuA, sapA, and hpe
genes showed a consistent trend to be higher in the
mutants than in the WT strain, being significant for
the hxuA and hpe genes when comparing their
expression in the WT and NTHi375ΔhbpA strains
(Figure 3(a)).
Bacteria sense heme as means to alert pathogens
upon contact with vertebrate tissues, thus modulating
expression of systems involved in heme acquisition
and metabolism [29,94]. Expression of genes encod-
ing most heme uptake systems increases when iron
or heme are restricted [95,96]. We next asked if gene
expression responsive to heme availability occurs in
a coordinated manner. NTHi375 WT and mutant
strains were grown in heme-deficient medium or in
sBHI for RNA purification and qRT-PCR analyses. In
NTHi375 WT, ΔhbpA, and Δhpe strains, expression
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of the hxuA, sapA, and hpe (the latter in WT and
ΔhbpA strains) genes was higher in heme-restricted
medium than in sBHI. In NTHi375 WT, ΔsapA, and
Δhpe strains, expression of the hbpA gene was lower
upon heme depletion. Lastly, hxuCBA gene inactiva-
tion seemed to hamper the effect of heme availability
on gene expression (Figure 3(b)).
Overall, these results support the notion that NTHi
heme acquisition machinery may act in a coordinated
manner, where HbpA seems to play a prominent role,
likely followed by PE, and HxuCBA and SapABCDFZ
participate in heme sensing, in turn having an impact
on the expression of other uptake systems.
SapA, HbpA, and HxuA participate in heme
donation to heme-starved NTHi bacterial cells
PE functions as a heme reservoir at the bacterial surface,
which can be donated to other H. influenzae bacterial cells
starved of heme [63]. We asked if this PE trait could be
extended to the other heme-binding proteins. Monitoring
heme donation as a means of luminescent emission
requires co-culturing a recipient luminescent strain starved
of heme and a donor strain cultured in the presence of
heme [63]. Unexpectedly, NTHi375 was a poor heme
donor, rendering very limited recipient growth (Fig.
S6A); in contrast, H. influenzae reference strain RdKW20,
which also contains the heme acquisition systems under
Figure 3. Expression of NTHi heme acquisition systems. (a) Expression of the hxuA, sapA, hbpA and hpe genes in NTHi375 WT, ΔhxuCBA,
ΔsapA, ΔhbpA, and Δhpe strains grown in sBHI. Expression of the hbpA gene was higher than that of hxuA, sapA, and hpe (WT strain, higher
expression of hbpA than that of hxuA (p < 0.05), sapA and hpe (p < 0.01); NTHi375ΔhxuCBA, higher expression of hbpA than that of sapA and
hpe (p < 0.0005); NTHi375ΔsapA, higher expression of hbpA than that of hxuA and hpe (p < 0.0005); NTHi375Δhpe, higher expression of hbpA
than that of hxuA (p < 0.05) and sapA (p < 0.0005)). Expression of the hxuA and hpe genes was higher in NTHi375ΔhbpA than in the WT strain
(p < 0.0001 and p < 0.01, respectively). Bottom panel: schematic representation of each gene expression compared to each other, in the WT
and mutant strains. Color code: blue, statistically significant differences; gray, not determined; white, no significant differences. Data are
shown as mean ± SEM. Statistical comparisons of the means were performed with two-way ANOVA (Tukey´s multiple comparisons test). (b)
Gene expression and heme sensing. In NTHi375 WT, ΔhbpA and Δhpe strains, hxuA, sapA, and hpe gene expression was higher in heme-
restricted medium than in sBHI (WT: hxuA (p < 0.001), sapA (p < 0.01), hpe (p < 0.001); NTHi375ΔhbpA: hxuA (p < 0.01), sapA (p < 0.05), hpe
(p < 0.0001); NTHi375Δhpe, hxuA, p < 0.05). In NTHi375WT, ΔsapA and Δhpe strains, expression of hbpAwas lower upon heme depletion (WT,
p < 0.0001; NTHi375ΔsapA, (p < 0.001); NTHi375Δhpe, p < 0.05). Data are shown as mean ± SEM. Statistical comparisons of the means were
performed with two-way ANOVA (Sidak´s multiple comparisons test).
VIRULENCE 323
study (hxuCBA, HI0262_HI0263_HI0264; sapABCDFZ,
HI1638_HI1639_HI1640_HI1641_HI1642_HI1643; hbpA,
HI0853) [97], donates heme at a significantly higher rate
(Figure 4(a)). While comparing NTHi375 and RdKW20
donor strains, we found that the hbpA gene expression was
significantly higher in the latter (Fig. S6B). This limitation
by NTHi375 led us to perform gene inactivation in
RdKW20 to analyze heme storage and inter-bacterial
donation. The growth of the generated mutants in sBHI
was comparable to that of the WT strain (Fig. S6C). We
assessed the use of heme derived from SapA, HbpA, and
HxuCBA by setting up co-cultures of NTH
i3655luxABCDE starved of heme with RdKW20 WT or
mutant strains cultured with heme. NTHi3655luxABCDE
grew better when incubated with RdKW20 WT as com-
pared to co-culture with RdKW20ΔsapA, RdKW20ΔhbpA,
or RdKW20ΔhxuCBA mutants (Figure 4(a)). We next
asked if heme interbacterial donation relates to its binding.
To do so, we employed the free iron-binding system
HitABC, in which HitA is a periplasmic protein that
binds free iron linked to the HitBC transporter located at
the inner membrane [98–101]. Inactivation of the hitABC
Figure 4. HxuCBA, SapA and HbpA participate in heme inter-bacterial donation. (a) Heme-starved NTHi 3655luxABCDE was
used as a heme-recipient strain. Heme donation allowed recipient´s growth, measured as a means of luminescence. NTHi
3655luxABCDE co-culture with Hi RdKW20 WT rendered significant recipient growth, comparable to that of NTHi 3655luxABCDE
grown in sBHI; in contrast, NTHi 3655luxABCDE co-culture with ΔhxuCBA, ΔsapA or ΔhbpA, did not promote recipient strain growth at
the same extent (see growth time points 4, 5 and 6 h). HitABC does not contribute to surface-bound heme inter-bacterial donation.
NTHi 3655luxABCDE co-culture with both Hi RdKW20 WT and ΔhitBC rendered significant recipient growth. White symbols, controls
showing recipient strain growth in sBHI (square) or BHI-NAD (circle). Black symbols, recipient strain growth when co-cultured with
WT (square) or mutant (circle) strains. *Indicates significant differences when comparing luminescence upon recipient co-culture
with WT (square) or mutant (circle) strains. Data are shown as luminescence arbitrary units (AU) and represent mean ± SEM values.
Statistical comparisons of the means were performed with two-way ANOVA (Bonferroni multiple comparisons test). (b) Semi-
quantitative measure of heme binding on the surface of Hi RdKW20 WT and mutant strains. Normalized bacterial suspensions were
2-fold serially diluted (OD600 = 0.1 and 0.05) and spotted on a PVDF filter. ECL was used for heme detection. Blots are representative
images of at least three independent experiments.
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system was performed in RdKW20 (HI0097_
HI0098_HI0099). Growth of the generated mutant in
sBHI was comparable to that of the WT strain (Fig. S6C).
When co-culturing NTHi3655luxABCDE starved of heme
with RdKW20ΔhitBC cultured with heme, NTH
i3655luxABCDE growth was comparable to that obtained
by co-culturing with theWT strain (Figure 4(a)), excluding
participation of this free iron transport system in heme
donation [98,99,101]. Lastly, deficiency in heme inter-
bacterial donation may relate to lower heme binding at
the bacterial surface. In fact, more heme was bound toWT
than to the hxuCBA, sapA, and hbpA mutants.
Unexpectedly, RdKW20ΔhitBC displayed a slight reduc-
tion in heme binding, but to a lower extent than that by the
ΔhxuCBA, ΔsapA, and ΔhbpA strains (Figure 4(b)).
Overall, these results suggest that heme binding may
work as a storage pool for heme to be shared between
H. influenzae bacterial cells during shortage. This ability
which was previously observed for the outer membrane
lipoprotein PE [63] is now extended to HxuCBA, SapA,
and HbpA.
Moonlighting features of H. influenzae
heme-binding systems
Besides heme binding, SapA is required for NTHi
resistance to antimicrobial peptides (AMP) and
potassium acquisition, HbpA is essential for glu-
tathione import, and PE binds extracellular matrix
proteins [62,91,102–106]. To get further insight on
the multi-functionality of the heme acquisition sys-
tems under study, we tested their contribution to
NTHi resistance to polymyxin E (PxE) as
a representative AMP. Inactivation of the hxuCBA,
sapA, and hpe genes rendered reduced MIC for this
AMP; conversely, hbpA gene inactivation increased
PxE MIC. Mutant strains showed comparable relative
phenotypes when grown in heme-deficient medium
or in sBHI (Figure 5(a)). Moreover, we tested their
contribution to glutathione import, a vital L-cysteine-
containing tripeptide mediating protection against
oxidative, xenobiotic, and metal iron stresses
[107,108]. H. influenzae is a cysteine and glutathione
auxotroph, and imports both molecules. Exogenous
cysteine and glutathione, and their oxidized forms
cystine and glutathione disulfide (GSSG), sustain
H. influenzae growth comparably [73].
NTHi375 WT and mutant strains were inoculated
in CDMM supplemented with cystine or GSSG.
CDMM supplemented with cystine sustained bacter-
ial growth in all cases. In contrast, CDMM supple-
mented with GSSG did not sustain NTHi375ΔhbpA
growth. NTHi375ΔsapA growth was lower than that
of the WT strain, but comparable in CDMM supple-
mented with cystine or GSSG (Figure 5(b)).
In conclusion, besides their common role in heme
binding, HxuCBA, SapA, and PE also account for AMP
resistance, and HbpA accounts for gluthatione import.
Figure 5. Moonlighting features of NTHi heme acquisition systems. (a) HxuCBA, SapABCDFZ and PE are involved in NTHi
resistance to PxE. MIC for PxE was shown to be lower for ΔhxuCBA, ΔsapA and Δhpe mutants than for the WT strain. Inactivation of
the hbpA gene rendered higher MIC for PxE. Bacterial inocula were prepared on heme-deficient or sBHI media. (b) HbpA, but not
HxuCBA, SapABCDFZ or PE, participates in glutathione import by NTHi. Bacteria were grown in CDMM supplemented with cystine or
GSSG. CDMM+cystine sustained bacterial growth in all cases. NTHi375ΔhbpA growth was lower in CDMM+GSSG than in CDMM
+cystine (at 2.5 h, p < 0.05; 3 h, p < 0.001; from 3.5 to 8 h p < 0.0001). Data are shown as mean ± SEM. Statistical comparisons of
the means were performed using two-way ANOVA (Tukey´s multiple comparisons test).
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NTHi heme acquisition systems contribute to host
airways-pathogen interplay
Production of dedicated heme scavenging machinery may
also relate to successful bacterial-host interplay [1,6]. We
asked whether inactivation of the systems under analysis
alters NTHi interplay with A549 type II human pneumo-
cytes. Epithelial invasion by NTHi375ΔhxuCBA,
NTHi375ΔsapA, NTHi375ΔhbpA, and NTHi375Δhpe
was lower than that observed for the WT strain (Figure 6
(a)). All strains stimulated epithelial IL-8 secretion, but
such inflammatory response was lower for
NTHi375ΔhxuCBA, NTHi375ΔsapA, and NTHi375Δhpe
than for theWT strain (Fig. S7A).We next assessed if heme
availability modulates the NTHi-host cell interplay by
growing NTHi375 WT and mutant strains in heme-
deficient medium or sBHI before infection. Epithelial inva-
sion for themutants was lower than for theWT strain in all
cases. Moreover, BHI-NAD rendered lower invasion when
compared to that of bacteria grown in sBHI. However,
while comparing invasion by BHI-NAD to that of sBHI
grown bacteria, the ratio of increased invasion upon
growth in sBHI was higher for the mutants (for
NTHi375ΔhxuCBA, 17.5-fold; for NTHi375ΔsapA, 42-
fold; for NTHi375ΔhbpA, 22.3-fold; for NTHi375Δhpe,
18.5-fold) than for the WT strain, 4.5-fold (Figure 6(b)).
At a lower extent, similar observations were obtained when
assessing epithelial adhesion (Fig. S7B). Last, we used an
in vivo mouse respiratory infection model system [79–
81,85,86]. At 24 hpi, NTHi375ΔhxuCBA lung and BALF
bacterial numbers were lower than those recovered for the
WT strain (Figure 6(c), left panels). At 48 hpi, the four
tested mutants rendered numbers lower than those of the
WT strain in both lung and BALF samples (Figure 6(c),
right panels).
In summary, these results support that, under the
conditions tested, inactivation of the HxuCBA,
SapABCDFZ, HbpA, and PE systems impairs airway
infection by NTHi, and that bacterial heme binding
may facilitate its interplay with host epithelial cells.
Discussion
Microorganisms have evolved or acquired a variety of
specialized iron uptake systems to overcome its envir-
onmental limitation and take up iron from extracellular
sources, including during infection [109]. For many
Gram negative bacteria (including uropathogenic
E. coli, Pseudomonas aeruginosa, Neisseria meningitidis,
Acinetobacter baumannii), Gram positive species
(Staphylococcus aureus), and fungal pathogens
(Candida albicans, Cryptococcus neoformans), heme
provides the potential for a rich source of iron [110].
Here, we tackled the H. influenzae case, a human host-
restricted opportunistic pathogen colonizing the lower
airways of patients who undergo iron homeostasis
unbalancing (i.e. COPD), and that requires exogenous
heme for aerobic respiration, lacks siderophore produc-
tion, and presents a panel of heme acquisition systems.
In this study, differential contribution of HxuCBA,
SapA, HbpA, and PE systems to NTHi respiratory
infection was evaluated.
The proteins HxuA, SapA, HbpA, and PE share the
ability to bind heme. We provide evidence for heme
binding to SapA and HbpA Cluster C substrate-
binding proteins (SBP) as well as information on
the shared predicted structural basis of such binding.
In fact, one striking feature of the Cluster C family is
that members play dual roles in nutrient uptake,
importing their canonical substrates and heme. In
NTHi, four Cluster C proteins with capability to
bind heme have been identified: HbpA, SapA, and
OppA, which bind hydrophobic oligopeptides, and
NTHI0310 with an unknown canonical substrate spe-
cificity. These proteins present overlapping function-
ality and multisubstrate specificity [90]. This may not
be exclusive to NTHi given that the E. coli Cluster
C nickel SBP NikA binds heme and plays a role as
a heme chaperone in the periplasm [111]. Regarding
HxuA, it should be stressed that our structural ana-
lyses may support heme binding, together with the
experimental evidence presented in Figure 4 whereas
previous data suggests heme binding to HxuC, when
expressed together with the NTHi TonB complex in
an E. coli heterologous host [53]. The mode of heme
binding to PE has been predicted previously [63], and
our docking analysis supports this and gives further
details about the residues involved.
Apart from the requirement for aerobic respiration,
bound heme may also be stored at the bacterial surface
or donated to neighboring heme-starved bacterial cells,
by contribution of these systems. SapA and HbpA are
predicted periplasmic proteins, and may need to be
coupled to other currently unknown bacterial systems
for effective heme uptake and donation. Moreover, we
should not exclude that deficiency in heme donation by
the sapA and hbpA mutants could also be an indirect
effect. We acknowledge that using RdKW20 mutants to
assess heme inter-bacterial donation may be a potential
limitation given our use of the NTHi375 strain in the
entire study, however, that it should be noted that
RdKW20 rendered a useful tool to generate this specific
information. Expression of the hxuA, sapA, and hpe
genes was comparable between NTHi375 and
RdKW20 WT strains, and was in parallel to expression
to the same level of the hitB, tonB, tbpA, and dppB
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Figure 6. NTHi heme acquisition systems contribute to the host airway-pathogen interplay. (a) Effect of heme uptake
inactivation in NTHi interplay with cultured cells. A549 cells were used to quantify invasion by NTHi375 WT, ΔhxuCBA, ΔsapA,
ΔhbpA and Δhpe strains. Gene inactivation rendered significantly lower entry into A549 cells than that shown by the WT strain
(ΔhxuCBA, p < 0.05; ΔsapA and Δhpe, p < 0.0001; ΔhbpA, p < 0.001). Mean ± SEM values are shown, statistical comparisons of the
means were performed using one-way ANOVA (Dunnett’s multiple comparison test). (b) Inactivation of heme-binding systems
lowers NTHi interaction with airway epithelial cells in a heme-dependent manner. BHI-NAD (gray bars) and sBHI (white bars) led to
decreased A549 invasion rates for the mutants, compared to that of the WT strain (p < 0.0001). Bacterial growth in sBHI increased
invasion rates, compared to BHI-NAD (for WT, ΔhxuCBA, ΔsapA and Δhpe, p < 0.0001). Top numbers indicate invasion fold increase
for each strain upon growth in sBHI compared to BHI-NAD. Mean ± SEM values are shown, statistical comparisons of the means were
performed using two-way ANOVA (Sidak’s multiple comparison test). (c) Effect of heme uptake inactivation in NTHi pulmonary
infection. CD1 mice were intranasally infected with WT and mutant strains, euthanized at 24 and 48 hpi, and bacterial loads
quantified. Results are reported as log10 CFU/lung and log10 CFU/ml BALF in upper and lower panels, respectively, and represented
as box plot graphs (lines inside boxes represent median values). Statistical comparisons were performed using one-way ANOVA
(Dunnett’s multiple comparison test). In the lungs, NTHi375ΔhxuCBA showed significantly lower loads at 24 hpi (ΔhxuCBA,
p < 0.0005), and all mutants showed significantly lower loads at 48 hpi (ΔhxuCBA, ΔsapA, p < 0.0001; ΔhbpA, p < 0.001; Δhpe,
p < 0.05) than those shown by the WT strain. In BALF samples, NTHi375ΔhxuCBA showed significantly lower loads at 24 hpi
(p < 0.0001), and all mutants showed significantly lower loads at 48 hpi (ΔhxuCBA, p < 0.05; Δhpe, p < 0.01; ΔsapA and ΔhbpA
p < 0.005) than those shown by the WT strain.
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heme-iron uptake related genes; only hbpA gene
expression was higher in RdKW20 than in NTHi375
strain, which could have an effect on the observed
differences between strain backgrounds (Fig. S6B).
Although the precise reason for limited heme inter-
bacterial donation by NTHi375 is unknown, we provide
several evidences suggesting heme binding at this bac-
terial surface: heme availability increased alveolar
epithelial infection by NTHi375, and also increased
NTHi375 susceptibility to PxE (more clearly shown
for WT, sapA, hxuCBA, and hpe mutant strains) sup-
porting the notion of AMP and heme competition for
binding to SapA [58], HxuA or PE.
When tackling a possible relationship among heme
uptake systems at the gene expression level, a prominent
role for HbpA was observed, based on its high expression
and on the effect of its inactivation on the expression of
the hxuA, sapA, and hpe genes, suggesting HbpA contri-
bution to down-regulating the activity of other heme
piracy systems. However, HbpA does not seem to parti-
cipate in heme sensing. In fact, in NTHi375 WT, ΔhbpA,
and Δhpe strains, expression of the hxuA, sapA, and hpe
genes was higher in heme-restricted than in sBHI med-
ium, supporting the notion that the expression of those
genes is up-regulated upon heme restriction in a HbpA-
and PE-independent manner. Conversely, in
NTHi375 WT, ΔsapA, and Δhpe strains, expression of
the hbpA gene was lower upon heme depletion, suggest-
ing hbpA gene expression being down-regulated upon
heme restriction in a SapABCDFZ- and PE-independent
manner. For unknown reasons, we noticed that expres-
sion of the hxuA, sapA, and hpe genes in NTHi375ΔhbpA
was higher when conventionally grown in sBHI (Figure 3
(a)) than in sBHI while assessing the effect of heme avail-
ability (Figure 3(b)). We acknowledge that BHI is
a medium with non-defined composition that could ren-
der reproducibility issues, and emphasize the importance
of preserving the use of exactly the same product in each
experimental design, as performed in this study. Although
to a lesser extent for HxuCBA, SapABCDFZ, and PE,
heme acquisition interlinks may contribute to regulating
the expression of the different systems, altogether compa-
tible with the notion of a coordinated heme uptake net-
work preventing toxicity by heme excess.
Notably, the heme uptake systems studied present
moonlighting features (summarized in Figure 7). We high-
light a relationship between NTHi heme acquisition and
AMPs. In addition to the already reported involvement of
SapABCDFZ in resistance to AMPs [102,103,112],
HxuCBA and PE also seem to subvert these elements of
the human soluble innate immunity. This was not the case
for NTHi375ΔhbpA, which could be linked to the observed
higher expression levels of the hxuA, sapA, and hpe genes
upon hbpA gene inactivation. Monitoring AMP resistance
was motivated by an earlier study where we conducted
a genomic analysis of three NTHi clonal isolates serially
collected from a bronchiectasis patient, which showed
increasing AMP resistance and carried amino acid substi-
tutions in SapABCDFZ and HxuCBA [113]. Based on that
and current observations, molecular crosstalk between
NTHi heme acquisition and AMP resistance will be
addressed in further studies. We also asked if glutathione
import could add to protein multi-functionality. This was
only the case for HbpA, in line with previous observa-
tions [62].
The use of cultured airway epithelia and murine pul-
monary infection model systems revealed a significant
involvement for heme binding systems in the bacterial-
host interplay. Data obtained for NTHi375Δhpe support
the role of PE as an adhesin [105,106]. In contrast, the
sapA gene inactivation has been shown to increase bacter-
ial invasiveness [104], which could relate to the use of
non-polarized (this study) versus polarized epithelial cells
grown at an air-liquid interface [104]. On the other hand,
increased invasion by the WT NTHi strain when pre-
grown in sBHI, and heme rescue of hxuCBA, sapA,
hbpA, and hpe mutant deficiencies upon epithelial infec-
tion, could relate to pathogen subversion of host cell heme
receptors such as heme uptake proteins HCP1 and HRG1
by using bound heme as a ligand. Our results somehow
differ from those shown by transient iron deprived bac-
teria developing intracellular bacterial communities
[64,114], which could relate to the use of different host
cell lines, bacterial strains, or growth conditions. A role
for HbpA and HxuCBA in causing bacteremia has been
shown in a rat model of invasive disease [55,60], and for
SapABCDFZ in a chinchilla model of otitis media (SapA,
SapF [103,112,115]) and a mouse model of lung infection
(SapF [116]). By using a mouse model of lung infection,
we expanded previous observations on HbpA, HxuCBA
and SapABCDFZ, and provided new roles for the PE
heme-acquisition system in vivo.
Figure 7. Schematic model showing moonlighting patterns by
HxuCBA, SapABCDFZ, HbpA-DppBCDF and PE heme acquisition
systems.
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In conclusion, the “iron-loving” bacterial species
H. influenzae has evolved redundant mechanisms to
obtain heme from the human host, and several of
them present specific moonlighting properties. We
also began elucidating the complex regulatory networks
used by NTHi to adapt to the host airways. In general
terms, pharmacological modification of host heme-iron
metabolism and/or acquisition may hold a key to
develop novel strategies to treat or prevent infection.
Iron chelators with improved pharmacokinetic proper-
ties may become important antimicrobials, and heme-
iron transporters and acquisition pathways attractive
targets for the development of new treatments to fight
infections in an era of increasing burden of antibiotic
resistance.
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